These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 491014)

  • 1. [CPK (creatine phosphokinase)].
    Ishiura S; Sugita H
    Nihon Rinsho; 1979 Jun; Suppl():1868-70. PubMed ID: 491014
    [No Abstract]   [Full Text] [Related]  

  • 2. [New test for determination of CPK activity].
    Ferracin GS
    Quad Sclavo Diagn; 1971 Mar; 7(1):462-8. PubMed ID: 4404534
    [No Abstract]   [Full Text] [Related]  

  • 3. [Creatine phosphokinase (CPK)--interpretation of the test results].
    Shoji S; Sugita H
    Nihon Rinsho; 1973; 31():1808-14. PubMed ID: 4582280
    [No Abstract]   [Full Text] [Related]  

  • 4. The value of the determination of cretaine phosphokinase activity (CPK) in certain diseases of the muscles.
    Hetnarska L
    Pol Med J; 1968; 7(3):742-6. PubMed ID: 5669716
    [No Abstract]   [Full Text] [Related]  

  • 5. Newborn screening for Duchenne muscular dystrophy.
    Zellweger H; Antonik A
    Pediatrics; 1975 Jan; 55(1):30-4. PubMed ID: 1110862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The serum-creatine phosphokinase (CPK) activity in amyotrophic lateral sclerosis (ALS) and other neurogenous muscular atrophies with regard to differential diagnostic aspects].
    Koufen H; Consbruch U
    Nervenarzt; 1970 Dec; 41(12):599-603. PubMed ID: 4924032
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum creatine phosphokinase in muscle disease. An evaluation of two methods of determination and comparison with serum aldolase.
    Bray GM; Ferrendelli JA
    Neurology; 1968 May; 18(5):480-4. PubMed ID: 5691174
    [No Abstract]   [Full Text] [Related]  

  • 8. Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study.
    Zatz M; Frota-Pessoa O; Levy JA; Peres CA
    J Genet Hum; 1976 Jun; 24(2):153-68. PubMed ID: 965952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Creatine phosphokinase: interpretation of the test results].
    Sugita H; Furukawa T; Chiba K
    Nihon Rinsho; 1969 Mar; ():Suppl:1072-7. PubMed ID: 4948291
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum creatine phosphokinase activity in Duchenne-type muscular dystrophy and carriers].
    Kato F; Takahashi K
    Iryo; 1968 Dec; 22(12):1386-91. PubMed ID: 5717705
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum creatine phosphokinase in the detection of carriers of Duchenne's muscular dystrophy in Northern Ireland.
    McCormick D; Allen IV
    Ulster Med J; 1976; 45(1):79-83. PubMed ID: 936362
    [No Abstract]   [Full Text] [Related]  

  • 12. The value of determination of serum creatine phosphokinase activity in detection of carriers of progressive muscular dystrophy.
    Hetnarska L
    Pol Med J; 1968; 7(1):224-7. PubMed ID: 5650194
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy].
    Ceccarelli A; Leone P
    Clin Pediatr (Bologna); 1967 May; 49(5):237-45. PubMed ID: 6080497
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of serum creatine phosphokinase and its isoenzymes in various muscular diseases].
    László A; Heiner L
    Orv Hetil; 1980 Jan; 121(3):139-40. PubMed ID: 7366978
    [No Abstract]   [Full Text] [Related]  

  • 15. Creatine phosphokinase MB band in oculopharyngeal muscular dystrophy.
    Diskin CJ
    N Engl J Med; 1979 Aug; 301(5):270. PubMed ID: 450000
    [No Abstract]   [Full Text] [Related]  

  • 16. Reassessment of the evidence for the role of secreted ADP in biphasic platelet aggregation. Mechanism of inhibition by creatine phosphate plus creatine phosphokinase.
    Huang EM; Detwiler TC
    J Lab Clin Med; 1980 Jan; 95(1):59-68. PubMed ID: 7350241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massive myoglobinuria precipitated by halothane and succinylcholine in a member of a family with elevation of serum creatine phosphokinase.
    Moore WE; Watson RL; Summary JJ
    Anesth Analg; 1976; 55(5):680-2. PubMed ID: 987723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal-blood creatine phosphokinase in the diagnosis of Duchenne's muscular dystrophy.
    N Engl J Med; 1978 Jun; 298(26):1479-80. PubMed ID: 652021
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of coenzyme Q on serum levels of creatine phosphokinase in preclinical muscular dystrophy.
    Folkers K; Nakamura R; Littarru GP; Zellweger H; Brunkhorst JB; Williams CW; Langston JH
    Proc Natl Acad Sci U S A; 1974 May; 71(5):2098-102. PubMed ID: 4525474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum creatine phosphokinase in various muscular diseases seen in the field of orthopedic surgery].
    Iwamoto A
    Igaku Kenkyu; 1969 May; 39(2):108-21. PubMed ID: 5389323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.